ArticleJournal of fluorescence2026
Dual-Mode "Turn-On/Off" Chemosensor for Trivalent Cations and Arsenate: Live Cell and Logic Gate Functionality.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study introduces a novel chemosensor (RbT) for the selective and highly sensitive detection of Al³⁺, Fe³⁺, Cr³⁺ (M³⁺) ions and arsenate anion (AsO₄³−). The sensor was synthesized through the strategic integration of Rhodamine B, phosphorus oxychloride, and Tryptamine, and operates via a chelation-enhanced fluorescence (CHEF) mechanism in an H₂O/ACN (3:7, pH 7) system. Upon coordination with M³⁺ ions, RbT exhibits a strong fluorescence enhancement and a visible deep-pink color change, enabling dual spectroscopic and visual detection. The sensor exhibits remarkable sensitivity within the micromolar range, with detection limits of 3.2 nM for Al³⁺, 5.6 nM for Fe³⁺, and 15.4 nM for Cr³⁺. Job’s plot and mass spectrometry confirm a 1:1 metal-ligand binding stoichiometry. The RbT-Al³⁺ complex further detects AsO₄³⁻ via a fluorescence quenching mechanism, achieving a detection limit of 2.8 nM. The reversible “Off-On-Off” fluorescence response enabled the construction of an INHIBIT molecular logic gate. The interaction between RbT and M3+ was reversible upon the addition of EDTA. Cytotoxicity and cell imaging studies using SHSY5Y and HeLa cell lines demonstrate low toxicity and efficient intracellular sensing. These results highlight RbT as a promising candidate for environmental analysis and bioanalytical applications.
Indexed as
Identifiers
41580583What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.